Key Points:
·Ispire Malaysia's subsidiary has announced that its production activities are intended exclusively for export.
·The company's products do not contain nicotine or marijuana ingredients, and are not sold in the Malaysian market.
·Its technology is only meant for adult use and within compliant regions.
Ispire Malaysia Sdn Bhd, a subsidiary of Ispire, reiterated on June 9th its strict compliance with all applicable laws and regulations in Malaysia.
Ispire Malaysia has confirmed that all production activities at its factory in Johor are solely for export and do not involve manufacturing or distributing any e-liquid or gel products containing nicotine or marijuana in Malaysia.
In a statement, Inspire's Co-CEO Michael Wang said:
"Ispire Malaysia operates under strict protocols to ensure that 100% of its production is for export. We believe our operations are fully compliant with Malaysian laws, and we are committed to maintaining transparency and cooperation at both federal and state levels."
Key clarifications include:
·Not distributed locally: All products manufactured in Malaysia are not sold, distributed, or marketed in the local market.
·No nicotine or marijuana ingredients: The factory only produces semi-finished vaporizer hardware, and the production process does not involve e-liquids or gel products.
·Not manufacturing medical devices: While the factory is capable of producing certified components, it has not currently produced any medical devices. Any future activities in this field will require comprehensive regulatory review.
·Advanced safety features: Ispire products will integrate age restrictions and geofencing technology based on blockchain, ensuring that only adults and compliant regions can use them. The company's patented technology has been submitted for review by the U.S. Food and Drug Administration (FDA).
The company pointed out that recent rumors about cannabis products pertain to its legal product marketing materials in the United States, and do not reflect the nature of its operations in Malaysia.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
